News

Brookfield had filed a non-binding offer on Nov. 19 for Grifols that valued the developer of human plasma-based drugs at ...
MADRID (Reuters) -Shares in Grifols jumped sharply on Wednesday morning after news website El Confidencial reported that Canadian fund Brookfield has resumed takeover talks with the Spanish ...
Four investment groups with ties to the family that owns about 35% of Grifols SA confirmed they are in talks with Brookfield Asset Management Ltd. over a potential offer for the Spanish blood-plasma ...
Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from website El Confidencial that it was ...
MADRID (Reuters) -Shares in Spanish pharmaceutical company Grifols rose on Wednesday after Canadian fund Brookfield said it was talking with shareholders, following a report from website El ...
IBL International GmbH, a Tecan company, which develops, manufactures and offers specialty diagnostics, today announced a ...
Canadian investment fund Brookfield (NYSE:BAM) resumed talks on a potential takeover of Spanish pharmaceuticals company Grifols (NASDAQ:GRFS), El Confidencial reported on Wednesday, citing ...
A private clinic that pays up to $100 for plasma donations has opened in Hamilton despite an attempt by city councillors to ...
Hamilton Mayor Andrea Horwath says she’s disappointed that a private plasma collection centre has opened in the city’s east ...
Ad-hoc RELEASE Announcement according to Article 17 European Market Abuse Regulation (MAR) Biotest AG: Delisting agreement and announced delisting tender offer eieich, March 31, 2025: Biotest AG (ISIN ...
Dow Jones Newswires is a market-moving financial and business news source, used by wealth managers, institutional investors and fintech platforms around the world to identify trading and investing ...
Shares in Grifols surged on Wednesday following a report that Canadian investment firm Brookfield had resumed takeover discussions with the Spanish pharmaceutical company.